SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (764)10/8/1997 3:07:00 PM
From: Linda Kaplan   of 23519
 
Headline: RESEARCH ALERT-J.P. Morgan starts pharmaceuticals

======================================================================
NEW YORK, Oct 8 (Reuter) - J.P. Morgan Securities Inc said
analyst Carl Seiden started coverage of five pharmaceutical
companies on Wednesday.
-- He rated Bristol-Myers Squibb Co (NYSE:BMY) and Pfizer Inc
(NYSE:PFE) with buy ratings.
-- Bristol-Myers, which he gave a one-year target price of
$106, was off 1-1/4 to 87-3/4. He said the company should
rebound as it repolishes its reputation and is a compelling
combination of positive earnings momentum and low relative
valuation.
-- Pfizer, given a 12-month price target of $73, was down
1-2/16 to 63-13/16. He said the stock is the best in its class
and should be a core holding in any growth portfolio.
-- Pharmacia & UpJohn Inc (NYSE:PNU) was rated long-term buy
and given a 12- to 18-month target of $42. The stock was up
1/16 to 34-1/16.
-- Merck and Co Inc was rated market perform and given an
18-month price target of $110. Shares were down 1-6/16 to
101-1/16.
-- Eli Lilly (NYSE:LLY) was started with a market perform
rating. Seiden gave the stock a 12-month price target of $135.
Shares were down 3-5/16 to 128-3/4.
-- The overall stock market was weak, with the Dow Jones
Industrial Average off 90 to 8087 or more than a full
percentage point.

Copyright 1997, Reuters News Service
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News